These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33740049)

  • 21. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 22. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
    Charleer S; De Block C; Bolsens N; Van Huffel L; Nobels F; Mathieu C; Gillard P
    Diabetes Technol Ther; 2023 Apr; 25(4):231-241. PubMed ID: 36648249
    [No Abstract]   [Full Text] [Related]  

  • 25. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
    Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring.
    Billion L; Charleer S; Verbraeken L; Sterckx M; Vangelabbeek K; De Block N; Janssen C; Van Dessel K; Dirinck E; Peiffer F; Bolsens N; Mathieu C; Gillard P; De Block C
    Diabetes Obes Metab; 2021 Dec; 23(12):2716-2727. PubMed ID: 34402157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
    Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
    Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study.
    Deshmukh H; Adeleke K; Wilmot EG; Folwell A; Barnes D; Walker N; Saunders S; Ssemmondo E; Walton C; Patmore J; Ryder REJ; Sathyapalan T
    Diabetes Obes Metab; 2024 Apr; 26(4):1333-1339. PubMed ID: 38164758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translation of personalized decision support into routine diabetes care.
    Augstein P; Vogt L; Kohnert KD; Heinke P; Salzsieder E
    J Diabetes Sci Technol; 2010 Nov; 4(6):1532-9. PubMed ID: 21129352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study.
    Danne T; Axel Schweitzer M; Keuthage W; Kipper S; Kretzschmar Y; Simon J; Wiedenmann T; Ziegler R
    Diabetes Technol Ther; 2021 Mar; 23(3):203-212. PubMed ID: 32924568
    [No Abstract]   [Full Text] [Related]  

  • 33. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
    Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study.
    Moreno-Fernandez J; Sastre J; Pinés P; Calderon-Vicente D; Gargallo J; Muñoz-Rodriguez JR
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Apr; 70(4):270-276. PubMed ID: 37116972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
    Davis TME; Dwyer P; England M; Fegan PG; Davis WA
    Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes.
    Cowart K; Updike W; Bullers K
    Diabetes Technol Ther; 2020 May; 22(5):337-345. PubMed ID: 31859531
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.
    Urakami T; Terada H; Yoshida K; Kuwabara R; Mine Y; Aoki M; Shoji Y; Suzuki J; Morioka I
    J Diabetes Investig; 2022 Oct; 13(10):1745-1752. PubMed ID: 35532954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.